Vol. 1 No. 2 (2022) | Bleeding, Thrombosis and Vascular Biology

Thrombophilia work-up and clinical outcomes in Indian patients with unprovoked venous and arterial thrombosis aged 18-50 years | BTVB Bioequivalence of von Willebrand factor-containing concentrates: implications for von Willebrand disease | BTVB Cardiovascular risk in hormone replacement therapy | BTVB Direct oral anticoagulants: does one dose fit all? Why, when and how testing | BTVB Cardiovascular risk profile evolution over 15 years: CV-PREVITAL vs Moli-sani Study | BTVB Launch of National Registry for Congenital Hematological Disorders in Palestine: Haemo-PAL | BTVB

Current Issue

Vol. 1 No. 2 (2022)

23 May 2022

View this Issue

Impact Factor 2025

Vol. 1 No. 2 (2022)

View Vol. 1 No. 2 (2022)

Published: 23 May 2022

Editorials

Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

Giovanni Tiscia, Elvira Grandone

https://doi.org/10.4081/btvb.2022.43

2622

PDF: 403
- PDF
Clonal hematopoiesis and inflammation: a link with thrombosis and malignancy

Tiziano Barbui

https://doi.org/10.4081/btvb.2022.38

3213

PDF: 452
- PDF

Reviews

The amazing genetic complexity of anucleated platelets

Loredana Bury, Paolo Gresele

https://doi.org/10.4081/btvb.2022.33

2525

PDF: 468
- PDF

Original Articles

Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa

https://doi.org/10.4081/btvb.2022.34

5501

PDF: 539

Supplementary Files: 243
- PDF
- Supplementary Files
Circulating albumin-to-fibrinogen ratio may be a risk indicator for venous thromboembolism: findings from a population-based prospective cohort study

Setor K. Kunutsor, Sudhir Kurl, Ari Voutilainen, Jari Laukkanen

https://doi.org/10.4081/btvb.2022.36

1608

PDF: 363
- PDF
A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele

https://doi.org/10.4081/btvb.2022.19

5209

PDF: 465
- PDF
Comparison among three different bleeding scores and the thrombin generation assay to assess the different hemorrhagic phenotypes in patients with FVII deficiency

Samantha Pasca, Cristina Santoro, Chiara Ambaglio, Marisanta Napolitano, Marta Milan, Letizia Natali, Silvia Nannizzi, Filippo Mori, Paolo Simioni, Ezio Zanon

https://doi.org/10.4081/btvb.2022.12

5543

PDF: 469
- PDF

Case Reports

Iatrogenic pseudoaneurysm of inferior epigastric artery: not only a surgical complication

Rossana Corso, Andrea Coppola, Stefano Grazioli, Cristina Dedionigi, Nicolò Tandurella, Massimo Venturini, Francesco Dentali

https://doi.org/10.4081/btvb.2022.25

1109

PDF: 341

Supplementary Video: 300
- PDF
- Supplementary Video
Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

https://doi.org/10.4081/btvb.2022.23

4418

PDF: 0

Letters to the Editor

Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators

https://doi.org/10.4081/btvb.2022.28

5674

PDF: 621

APPENDIX: 0
- PDF

© PAGEPress 2008-2026 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.